Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy (Q36616439)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on March 2005

Language	Label	Description	Also known as
English	Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy	scientific article published on March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Z A Nurgat

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

W Craig

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

N C Campbell

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J D Bissett

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Cassidy

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M C Nicolson

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

92

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1001-1005

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: theory and practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Striking the right balance in colorectal cancer care--a qualitative study of rural and urban patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Cancer patients' information needs and information seeking behaviour: in depth interview study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Volunteers or victims: patients' views of randomised cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

False hopes and best data: consent to research and the therapeutic misconception

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Responses and toxic deaths in phase I clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

30 September 2017

Impact of quality of life on patient expectations regarding phase I clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

28 June 2018

Expectations and experiences of patients with cancer participating in phase I clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

28 June 2018

The recruitment of patients into clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

28 June 2018

Patient motivation and informed consent in a phase I study of an anticancer agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

28 June 2018

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

20 September 2018

Patients' understanding of risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

20 September 2018

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

20 September 2018

Informed consent for investigational chemotherapy: patients' and physicians' perceptions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

21 October 2018

Strategic physician communication and oncology clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic misconception and the appreciation of risks in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response in phase I trials of antineoplastic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

1 reference

https://pubmed.ncbi.nlm.nih.gov/15770219

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6602423

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36616439&oldid=2232780752"